News & Updates

Individuals with more components of cardiovascular–kidney–metabolic (CKM) syndrome, as defined by the American Heart Association, are at increased risks of all-cause mortality, cardiovascular disease (CVD) mortality, and end-stage kidney disease (ESKD), suggests a study.

Inhaled insulin appears to be equally efficacious and safe as the injected rapid-acting insulin analogue in children and adolescents with diabetes, according to data from the INHALE-1 study.

For adults with early type 2 diabetes (T2D) not adequately controlled by diet and exercise alone, treatment with the investigational small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron yields significant reductions in glycated haemoglobin levels, according to data from the phase III ACHIEVE-1 trial.